Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

Participants will receive TBA-7371 oral suspension 100 milligram (mg) once daily (QD) for 14 days.

Participants will receive TBA-7371 oral suspension 100 mg twice daily (BID) for 14 days.

Participants will receive TBA-7371 oral suspension 200 mg QD for 14 days.

Participants will receive TBA-7371 oral suspension 100 mg three times daily (TID) for 14 days.

Participants will receive TBA-7371 oral suspension 400 mg QD for 14 days.

Participants will receive Isoniazid \[H\] / rifampicin \[R\] / pyrazinamide \[Z\] / ethambutol \[E\] (HRZE), a fixed dose combination tablet QD for 14 days, based on weight as 40-54 kilograms (kg): 3 tablets; 55-70 kg: 4 tablets and 71 kg and over: 5 tablets.